» Articles » PMID: 8726017

In Vitro Trypanocidal Activities of New S-adenosylmethionine Decarboxylase Inhibitors

Overview
Specialty Pharmacology
Date 1996 Jun 1
PMID 8726017
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A series of novel aromatic derivatives based on the structure of methylglyoxal bis(guanylhydrazone) (MGBG) was examined for in vitro antitrypanosomal activities and cytotoxicities for human cells. One-third of the compounds tested showed trypanocidal activity at concentrations below 0.5 microM after an incubation period of 72 h. Structure-activity analysis revealed that bicyclic compounds with homocyclic rings and unmodified termini were the most active compounds. Results obtained in three laboratories employing different methods and trypanosome populations consistently ranked compound CGP 40215A highest. This compound had a 50% inhibitory concentration of 0.0045 microM for Trypanosoma brucei rhodesiense, was also active against other trypanosome species, including a multidrug-resistant Trypanosoma brucei brucei, and was significantly less toxic than other compounds tested for a human adenocarcinoma cell line, with a 50% inhibitory concentration of 1.14 mM. The effect of CGP 40215A was time and dose dependent, and low concentrations of the compound required exposure times of > 2 days to exert trypanocidal activity. Compounds were inactive against Leishmania donovani and Trypanosoma cruzi amastigotes in murine macrophages in vitro.

Citing Articles

Polyamine Metabolism for Drug Intervention in Trypanosomatids.

Perez-Pertejo Y, Garcia-Estrada C, Martinez-Valladares M, Murugesan S, Reguera R, Balana-Fouce R Pathogens. 2024; 13(1).

PMID: 38251386 PMC: 10820115. DOI: 10.3390/pathogens13010079.


Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine.

Guhe V, Ingale P, Tambekar A, Singh S Front Mol Biosci. 2023; 10:1113249.

PMID: 37152895 PMC: 10160387. DOI: 10.3389/fmolb.2023.1113249.


Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads.

Hubin T, Walker A, Davilla D, Freeman T, Epley B, Hasley T Polyhedron. 2019; 163:42-53.

PMID: 30976133 PMC: 6452907. DOI: 10.1016/j.poly.2019.02.027.


Polyamines in protozoan pathogens.

Phillips M J Biol Chem. 2018; 293(48):18746-18756.

PMID: 30333232 PMC: 6290135. DOI: 10.1074/jbc.TM118.003342.


Emerging therapeutic targets for treatment of leishmaniasis.

Sundar S, Singh B Expert Opin Ther Targets. 2018; 22(6):467-486.

PMID: 29718739 PMC: 6047532. DOI: 10.1080/14728222.2018.1472241.


References
1.
Pegg A . Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 1988; 48(4):759-74. View

2.
Porter C, Sufrin J . Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res. 1986; 6(4):525-42. View

3.
Kaminsky R, Zweygarth E . Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi. Antimicrob Agents Chemother. 1989; 33(6):881-5. PMC: 284250. DOI: 10.1128/AAC.33.6.881. View

4.
Kaminsky R, Chuma F, Zweygarth E . Trypanosoma brucei brucei: expression of drug resistance in vitro. Exp Parasitol. 1989; 69(3):281-9. DOI: 10.1016/0014-4894(89)90074-x. View

5.
Hirumi H, Hirumi K . Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol. 1989; 75(6):985-9. View